Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report)’s share price rose 10% on Monday . The company traded as high as C$2.42 and last traded at C$2.42. Approximately 18,776 shares traded hands during mid-day trading, an increase of 448% from the average daily volume of 3,427 shares. The stock had previously closed at C$2.20.
Genscript Biotech Stock Up 10.0%
The business’s fifty day simple moving average is C$2.12 and its two-hundred day simple moving average is C$1.79.
About Genscript Biotech
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.
Read More
- Five stocks we like better than Genscript Biotech
- How to invest in marijuana stocks in 7 steps
- Reddit Hits Record Highs: Why Wall Street Is Taking Notice
- What Are the U.K. Market Holidays? How to Invest and Trade
- After a Strong Wall Street Debut, Klarna’s Real Work Begins
- How to Evaluate a Stock Before Buying
- 3 Dividend Growers That Fly Under the Radar
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
